Dr. Roger D. Klein is an expert with the Regulatory Transparency Project’s FDA and Health Working Group and has now written extensively on vaping. He is the former Medical Director of Molecular Oncology at the Cleveland Clinic, a former adviser to the FDA, CDC, CMS, and HHS. He discusses the intricacies of the "flavor ban" and its likely impact on vapers and smokers.